Dana Investment Advisors’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-13,375
Closed -$1.93M 573
2025
Q3
$1.93M Sell
13,375
-3,723
-22% -$456K 0.06% 304
2025
Q2
$1.72M Sell
17,098
-1,348
-7% -$103K 0.06% 308
2025
Q1
$1.41M Sell
18,446
-2,747
-13% -$210K 0.05% 330
2024
Q4
$1.46M Sell
21,193
-403
-2% -$29K 0.05% 336
2024
Q3
$1.58M Sell
21,596
-1,380
-6% -$102K 0.05% 326
2024
Q2
$1.54M Sell
22,976
-714
-3% -$27.7K 0.05% 329
2024
Q1
$643K Buy
23,690
+8,060
+52% +$226K 0.02% 414
2023
Q4
$484K Buy
15,630
+265
+2% +$6.87K 0.02% 328
2023
Q3
$388K Buy
+15,365
New +$351K 0.02% 342

Other funds holding INSM

Dana Investment Advisors's INSM Position: Q4 2025 in Review

Dana Investment Advisors sold out of Insmed (INSM) in Q4 2025, closing a stake of 13,375 shares — an estimated $1.93M sold.

Dana Investment Advisors first reported a position in INSM in Q3 2023 and held it in 9 quarters. The position peaked at $1.93M in Q3 2025. 677 funds tracked by Wall St. Rank hold INSM as of Q4 2025.

  • Dana Investment Advisors reported no remaining Insmed position as of Q4 2025 after selling out during the quarter.
  • Dana Investment Advisors sold 13,375 Insmed shares in Q4 2025, an estimated $1.93M.
  • Dana Investment Advisors first reported a position in Insmed in Q3 2023 and held it in 9 quarters.
  • Dana Investment Advisors's Insmed position peaked at $1.93M in Q3 2025.
  • 677 funds tracked by Wall St. Rank held Insmed as of Q4 2025.

Based on Dana Investment Advisors's 13F filing for Q4 2025, filed 5 Feb 2026.